Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

521
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
521
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

574
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
574
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

374
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
374
Heart Valves01:16

Heart Valves

12.1K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
12.1K
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

618
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
618
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

548
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
548

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiographic assessment in arterial hypertension: a contemporary narrative review.

Echo research and practice·2026
Same author

EACVI survey on the use of multi-modality cardiovascular imaging in immune-mediated inflammatory diseases.

European heart journal. Imaging methods and practice·2026
Same author

Improvement in cardiovascular function after atrial fibrillation ablation in heart failure: association with ECG and echocardiographic variables.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Myocardial relaxation, left ventricular filling, and exercise capacity in older subjects with dyspnea.

American journal of physiology. Heart and circulatory physiology·2026
Same author

Diagnostic Impact of Contrast Echocardiography in Chronic Chagas Disease: A Single-Centre Experience.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography·2026
Same author

Echocardiography in cardio-oncology: optimising service delivery.

Echo research and practice·2026

Related Experiment Video

Updated: Feb 2, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.4K

Mitral valve prolapse.

Aeshah Althunayyan1,2, Steffen E Petersen1,2, Guy Lloyd1,2,3

  • 1a Barts Heart Centre, St Bartholomew's Hospital , Barts Health NHS Trust , London , UK.

Expert Review of Cardiovascular Therapy
|November 29, 2018
PubMed
Summary
This summary is machine-generated.

Mitral valve prolapse (MVP) management is complex. For asymptomatic severe mitral regurgitation, risk stratification is crucial to determine optimal intervention timing, as progression factors and complication prevention remain unclear.

Keywords:
Mitral valve prolapsecardiac surgerydegenerative mitral regurgitationechocardiographyheart valvesmitral regurgitation

More Related Videos

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.4K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.4K

Related Experiment Videos

Last Updated: Feb 2, 2026

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

2.4K
Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve
09:13

Optimized Protocol for the Extraction of Proteins from the Human Mitral Valve

Published on: June 14, 2017

13.4K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.4K

Area of Science:

  • Cardiology
  • Valvular Heart Disease

Background:

  • Mitral valve prolapse (MVP) is a common cardiac condition with varied severity, from isolated prolapse to Barlow's disease.
  • Complications include mitral regurgitation, endocarditis, sudden cardiac death, and stroke.
  • Optimal intervention timing for asymptomatic severe mitral regurgitation remains a clinical dilemma.

Purpose of the Study:

  • To review the pathophysiology, genetics, clinical features, diagnostic imaging, complications, outcomes, and intervention indications for MVP.
  • To discuss current challenges and controversies in MVP management.

Main Methods:

  • Literature review of pathophysiology, genetics, clinical presentation, imaging, complications, and outcomes of MVP.
  • Analysis of current evidence regarding indications for intervention in symptomatic and asymptomatic patients.

Main Results:

  • Progression factors for mitral regurgitation in MVP are not well-defined, limiting targeted preventative therapies.
  • Evidence-based strategies to mitigate risks of sudden death, stroke, and endocarditis in MVP are lacking.
  • Surgical intervention is recommended for symptomatic severe mitral regurgitation.

Conclusions:

  • Management of MVP requires careful risk stratification in asymptomatic patients, considering left ventricular function, atrial fibrillation, pulmonary hypertension, and valve repairability.
  • Further research is needed to identify factors influencing MVP progression and to develop preventative strategies for major complications.